ANGO— ANGIODYNAMICS INC

Health Care$664M mkt cap

Metric	FY2026	FY2025	FY2024	FY2023
Net sales	$320.2M+9.5%	$292.5M-3.8%	$303.9M-10.3%	$338.8M
Cost of sales (exclusive of intangible amortization)	$145.3M+7.8%	$134.8M-9.7%	$149.2M-9.3%	$164.5M
Gross margin	$174.9M+10.9%	$157.7M+1.9%	$154.7M-11.2%	$174.2M
Research and development	$29.4M+12.3%	$26.2M-16.8%	$31.5M+5.5%	$29.9M
Sales and marketing	$113.4M+10.0%	$103.1M+0.3%	$102.8M-1.4%	$104.2M
General and administrative	$43.7M+3.8%	$42.1M+2.3%	$41.2M+2.9%	$40.0M
Amortization of intangibles	$10.7M+3.5%	$10.3M-20.9%	$13.0M-30.6%	$18.8M
Goodwill impairment	$0	$0-100.0%	$159.5M+996.1%	$14.5M
Change in fair value of contingent consideration	$0-100.0%	$272K-37.0%	$432K-81.4%	$2.3M
Acquisition, restructuring and other items, net	$17.6M+12.7%	$15.6M-70.6%	$53.2M+240.2%	$15.6M
Total operating expenses	$214.8M+8.7%	$197.7M-50.8%	$401.6M+78.2%	$225.4M
Gain on sale of assets	$0	$0-100.0%	$54.5M	$0
Operating loss	-$39.9M+0.1%	-$40.0M+79.2%	-$192.4M-276.0%	-$51.2M
Interest income (expense), net	-$299K-130.6%	$978K-39.4%	$1.6M+159.7%	-$2.7M
Other income (expense), net	$3.9M-20.6%	$4.9M+705.1%	-$817K-47.5%	-$554K
Total other income, net	$3.6M-38.8%	$5.9M+643.0%	$797K+124.5%	-$3.3M
Loss before income tax expense (benefit)	-$36.3M-6.7%	-$34.0M+82.2%	-$191.6M-252.0%	-$54.4M
Income tax expense (benefit)	$442K+1233.3%	-$39K+99.5%	-$7.3M-265.4%	-$2.0M
Net loss	-$36.7M-8.1%	-$34.0M+81.6%	-$184.3M-251.5%	-$52.4M
Basic (usd per share)	-$0.88+99.9%	-$830.00+81.9%	-$4590.00-245.1%	-$1330.00
Diluted (usd per share)	-$0.88+99.9%	-$830.00+81.9%	-$4590.00-245.1%	-$1330.00
Basic (in shares)	41.53B+1.6%	40.85B+1.7%	40.18B+1.8%	39.48B
Diluted (in shares)	41.53B+1.6%	40.85B+1.7%	40.18B+1.8%	39.48B

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 13 more years of annual history and full quarterly detail on Pro.

Upgrade to Pro →

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.